HPTN Studies

HPTN research studies are developed by protocol teams that include CTU investigators and recognized experts in HIV prevention. As study protocols are developed, they undergo a rigorous intra- and extra-network review process that ensures compliance with current ethical guidelines and regulatory procedures.

Each Study Protocol is available once version 1.0 is approved and distributed to the performance sites. The CORE Protocol Contact can provide additional information and materials.

Recent Publications

Landovitz R, Donnell D, Clement M, Hanscom B, Cottle L, Coelho L . Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. NEJM. 2021, 385: 595-608
Connie Celum ,Sybil Hosek,Mandisa Tsholwana,Sheetal Kassim,Shorai Mukaka,Bonnie J. Dye,Subash Pathak,Nyaradzo Mgodi,Linda-Gail Bekker,Deborah J. Donnell,Ethan Wilson,Krista Yuha,Peter L. Anderson,Yaw Agyei,Heather Noble,Scott M. Rose,Jared M. Baeten,Jessi, C Celum, S Hosek, M Tsholwana, S Kassim, S Mukaka, B J. Dye, S Pathak, N Mgodi, LG Bekker, D J. Donnell, E Wilson, K Yuha, P L. Anderson, Y Agyei, H Noble, S M. Rose, J M. Baeten, J M. Fogel, A Adeyeye, L Wiesner, J Rooney, S Delany-Moretlwe . PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. PLoS Med. 2021
Whitfield DL, Beauchamp G, Fields S, Nelson L, Magnus M, Dacus JD, Paul J, Anderson P, Wheeler D . Risk Compensation in HIV Prep Adherence among Black Men Who Have Sex with Men in HPTN 073 Study.. AIDS Care. 2021, 33: 633-638
Zeziulin O, Mollan KR, Shook-Sa BE, Hanscom B, Lancaster KE, Dumchev K, Go VF, Chu VA, Kiriazova T, Syarif Z, Dvoryak S, Reifeis SA, Hamilton E, Sarasvita R, Rose S, Richardson P, Clarke W, Latkin CA, Metzger DS, Hoffman IF, Miller WC . Depressive Symptoms and Use of Hiv Care and Medication-Assisted Treatment among People with Hiv Who Inject Drugs [HPTN 074]. AIDS. 2021, 35: 495-501
Irvin R, Gamble T, Malone J, Wang Z, Wilson E, Hughes JP, Farley J, Mayer KH, Del Rio C, Batey DS, Cummings V, Remien RH, Beyrer C, Thio CL . HPTN 078: High Prevalence of HCV Antibodies among Urban U.S. Men Who Have Sex with Men (Msm) Independent of HIV Status. Clin Infect Dis. 2020
Moore JR, Donnell DJ, Boily MC, Mitchell KM, Delany-Moretlwe S, Bekker LG, Mgodi NM, El-Sadr W, Cohen MS, Celum CL, Dimitrov D . Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression [HPTN 082]. Journal of Acquired Immune Deficiency Syndromes. 2020, 85: 423-429

Scholars Program

The HIV Prevention Trials Network (HPTN) is proud to offer two scholarship programs for early-career investigators funded through a supplement from the National Institute of Allergy and Infectious Diseases (NIAID). The HPTN Scholars Program now includes two components: a domestic (U.S.) program and an international program. Both programs seek to increase opportunities for scientists from groups under-represented in HIV prevention research.

In the domestic program, successful applicants will be Investigators who have received their terminal degree (MD, Phd, etc). For the international version, current MD, PhD, and MBChB students may apply, along with individuals having already graduated with their terminal degree. In both programs, applicants should desire to work with a mentor scientist in the Network to complete a research project based upon an existing HPTN research study.

Learn more about the Scholars Program